Back
Citius Pharmaceuticals Vs. Citius Oncology Industry Stock Comparison
Sell
20
CTXR
Citius Pharmaceuticals
Last Price:
0.34
Seasonality Move:
14.95%
Sell
1
CTOR
Citius Oncology
Last Price:
1.22
Seasonality Move:
--
Sell
20
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.35. The Score for CTXR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy, Sell or Hold?
- The current Citius Oncology [CTOR] share price is $1.19. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight selling pressure.
CTOR Stock Price Chart
What is Citius Oncology's stock price today?
-
The Citius Oncology share price today is $1.19
The current trend is relatively stagnant and CTOR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 36.17 | Sell |
| Chaikin Money Flow: | -34056 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.42) | Sell |
| Bollinger Bands (100): | (0.42 - 0.78) | Sell |
CTOR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 45.49 | Sell |
| Chaikin Money Flow: | 145001 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.24) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Sell |
| 20-day SMA: | 0.37 | Sell |
| 50-day SMA: | 0.47 | Sell |
| 200-day SMA: | 0.66 | Sell |
| 8-day EMA: | 0.36 | Sell |
| 20-day EMA: | 0.39 | Sell |
| 50-day EMA: | 0.46 | Sell |
| 200-day EMA: | 0.65 | Sell |
CTOR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Buy |
| 20-day SMA: | 1.13 | Buy |
| 50-day SMA: | 1.39 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 1.16 | Buy |
| 20-day EMA: | 1.19 | Sell |
| 50-day EMA: | 1.44 | Sell |
| 200-day EMA: | 0.03 | Buy |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Citius Oncology Earnings Growth & CTOR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Citius Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Citius Oncology Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||